Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 212 | - | - | 43 | 20.3 | 44 | 20.8 | 94 | 44.3 | 31 | 14.6 |
2015-2019 | 210 | 1 | 0.5 | 40 | 19.0 | 43 | 20.5 | 91 | 43.3 | 35 | 16.7 |
2014-2018 | 206 | 1 | 0.5 | 41 | 19.9 | 40 | 19.4 | 86 | 41.7 | 38 | 18.4 |
2013-2017 | 206 | 1 | 0.5 | 35 | 17.0 | 35 | 17.0 | 95 | 46.1 | 40 | 19.4 |
2012-2016 | 184 | 2 | 1.1 | 32 | 17.4 | 33 | 17.9 | 81 | 44.0 | 36 | 19.6 |
2011-2015 | 183 | 2 | 1.1 | 34 | 18.6 | 36 | 19.7 | 76 | 41.5 | 35 | 19.1 |
2010-2014 | 174 | 1 | 0.6 | 31 | 17.8 | 37 | 21.3 | 75 | 43.1 | 30 | 17.2 |
2009-2013 | 181 | 1 | 0.6 | 35 | 19.3 | 40 | 22.1 | 84 | 46.4 | 21 | 11.6 |
2008-2012 | 185 | 1 | 0.5 | 38 | 20.5 | 45 | 24.3 | 84 | 45.4 | 17 | 9.2 |
2007-2011 | 205 | - | - | 39 | 19.0 | 47 | 22.9 | 97 | 47.3 | 22 | 10.7 |
2006-2010 | 218 | - | - | 43 | 19.7 | 50 | 22.9 | 102 | 46.8 | 23 | 10.6 |
2005-2009 | 229 | - | - | 44 | 19.2 | 52 | 22.7 | 105 | 45.9 | 28 | 12.2 |
2004-2008 | 218 | - | - | 39 | 17.9 | 51 | 23.4 | 95 | 43.6 | 33 | 15.1 |
2003-2007 | 216 | - | - | 43 | 19.9 | 45 | 20.8 | 86 | 39.8 | 42 | 19.4 |
2002-2006 | 203 | - | - | 39 | 19.2 | 55 | 27.1 | 72 | 35.5 | 37 | 18.2 |
2001-2005 | 189 | - | - | 32 | 16.9 | 57 | 30.2 | 67 | 35.4 | 33 | 17.5 |
2000-2004 | 184 | - | - | 31 | 16.8 | 61 | 33.2 | 65 | 35.3 | 27 | 14.7 |
1999-2003 | 189 | - | - | 32 | 16.9 | 64 | 33.9 | 67 | 35.4 | 26 | 13.8 |
1998-2002 | 180 | - | - | 28 | 15.6 | 63 | 35.0 | 71 | 39.4 | 18 | 10.0 |
1997-2001 | 183 | - | - | 32 | 17.5 | 53 | 29.0 | 80 | 43.7 | 18 | 9.8 |
1996-2000 | 173 | - | - | 37 | 21.4 | 43 | 24.9 | 71 | 41.0 | 22 | 12.7 |
1995-1999 | 167 | - | - | 37 | 22.2 | 34 | 20.4 | 72 | 43.1 | 24 | 14.4 |
1994-1998 | 171 | - | - | 40 | 23.4 | 35 | 20.5 | 69 | 40.4 | 27 | 15.8 |
1993-1997 | 178 | - | - | 34 | 19.1 | 37 | 20.8 | 70 | 39.3 | 37 | 20.8 |
1992-1996 | 160 | - | - | 29 | 18.1 | 34 | 21.3 | 59 | 36.9 | 38 | 23.8 |
1991-1995 | 171 | - | - | 29 | 17.0 | 39 | 22.8 | 68 | 39.8 | 35 | 20.5 |
1990-1994 | 176 | - | - | 27 | 15.3 | 39 | 22.2 | 65 | 36.9 | 45 | 25.6 |
1989-1993 | 162 | 1 | 0.6 | 20 | 12.3 | 27 | 16.7 | 65 | 40.1 | 49 | 30.2 |
1988-1992 | 153 | 1 | 0.7 | 21 | 13.7 | 26 | 17.0 | 58 | 37.9 | 47 | 30.7 |
1987-1991 | 152 | 2 | 1.3 | 20 | 13.2 | 25 | 16.4 | 54 | 35.5 | 51 | 33.6 |
1986-1990 | 133 | 3 | 2.3 | 12 | 9.0 | 19 | 14.3 | 50 | 37.6 | 49 | 36.8 |
1985-1989 | 122 | 3 | 2.5 | 13 | 10.7 | 20 | 16.4 | 43 | 35.2 | 43 | 35.2 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |